Several advances in non-viral gene transfer technology have been reported over the past year. Cationic lipids have been successfully used to deliver genes in vivo, providing a clear alternative to recombinant viruses. In addition, investigators have demonstrated that direct application of DNA via in
Innovative approaches to gene therapy
โ Scribed by Vincent Cunliffe; David Thatcher; Roger Craig
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 424 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0958-1669
No coin nor oath required. For personal study only.
โฆ Synopsis
The past year has witnessed several advances in the development of targeted, cell-specific gene delivery systems of both viral and non-viral origin. Progress has been made in understanding the cellular mechanisms of nuclear import, and novel sequence-specific integrases have been developed that mediate insertion of DNA molecules into specific target sequences. Knowledge of the mechanisms by which herpes simplex virus and Epstein-Barr virus escape from immune surveillance has also advanced significantly; this may be exploited to reduce the immunogenicity of certain therapeutic gene products.
๐ SIMILAR VOLUMES
The aim of Dr Vile's laboratory at Mayo is the development of targeted and efยฎcient vectors for the delivery of cytotoxic and immunostimulatory genes for the gene therapy of cancer. JGM: Could you explain the herpes virus DISC vector approach?
Increasing antibiotic resistance in microorganisms and new emerging pathogens have become a major problem in our society. Rising to satisfy this urgent medical need is a recent confluence of powerful new drug discovery technologies: combinatorial chemistry; sequence and functional genomic analysis;